| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,866 | $93.97 | $175,343.52 | -0.7% | +3.8% | +60.8% | |
| May 1, 2024 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 10,000 | $573.74 | $5,737,355.93 | -0.8% | +7.0% | -27.0% | |
| May 1, 2024 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 136 | $60.15 | $8,180.40 | -1.1% | -22.4% | -21.4% | |
| May 1, 2024 | EXAS Exact Sciences Corp | Coward D Scott77 | Director | Sell | 67 | $60.15 | $4,030.05 | -0.1% | -22.4% | -21.4% | |
| May 1, 2024 | EXAS Exact Sciences Corp | Herriott James75 | SVP, General Counsel &Sec | Sell | 30 | $60.15 | $1,804.50 | -0.3% | -22.4% | -21.4% | |
| May 1, 2024 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 1,155 | $60.15 | $69,473.25 | - | -22.4% | -21.4% | |
| May 1, 2024 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 102 | $60.15 | $6,135.30 | -0.1% | -22.4% | -21.4% | |
| May 1, 2024 | EXAS Exact Sciences Corp | Cunningham Everett54 | Chief Commercial Officer | Sell | 136 | $60.15 | $8,180.40 | -0.3% | -22.4% | -21.4% | |
| May 1, 2024 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, Screening | Sell | 102 | $60.15 | $6,135.30 | -0.7% | -22.4% | -21.4% | |
| May 1, 2024 | EXAS Exact Sciences Corp | Baranick Brian75 | EVP, Gm., Precision Oncology | Sell | 110 | $60.15 | $6,616.50 | -0.8% | -22.4% | -21.4% | |
| Apr 30, 2024 | PSNL Personalis, Inc. | Moore Stephen Michael52 | SVP And Chief Legal Officer | Sell | 4,523 | $1.37 | $6,196.51 | -5.9% | +104.4% | +157.1% | |
| Apr 30, 2024 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 16,930 | $400.65 | $6,782,987.06 | -1.1% | -0.8% | -20.6% | |
| Apr 30, 2024 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $574.18 | $11,483,531.55 | -1.0% | +6.2% | -24.6% | |
| Apr 29, 2024 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 6,325 | $11.04 | $69,807.76 | -7.7% | +206.3% | +963.4% | |
| Apr 29, 2024 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 4,084 | $93.14 | $380,378.45 | -1.8% | +10.3% | +64.7% | |
| Apr 29, 2024 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 1,057 | $93.14 | $98,447.61 | -0.5% | +10.3% | +64.7% | |
| Apr 29, 2024 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 929 | $93.14 | $86,525.85 | -0.8% | +10.3% | +64.7% | |
| Apr 29, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 1,104 | $11.04 | $12,184.63 | -3.5% | +206.3% | +963.4% | |
| Apr 29, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,238 | $93.14 | $115,305.71 | -1.8% | +10.3% | +64.7% | |
| Apr 29, 2024 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 1,196 | $93.14 | $111,393.89 | -1.0% | +10.3% | +64.7% | |
| Apr 26, 2024 | TMO Thermo Fisher Scientific Inc. | Boxer Michael A59 | SVP And General Counsel | Sell | 2,000 | $567.94 | $1,135,880.00 | -13.3% | +3.6% | -26.0% | |
| Apr 26, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,393 | $91.67 | $219,364.91 | -1.1% | +11.4% | +67.8% | |
| Apr 25, 2024 | DHR Danaher Corp /de/ | Weidemanis Joakim67 | Executive Vice President | Sell | 22,433 | $250.46 | $5,618,569.18 | -19.9% | +8.1% | -19.8% | |
| Apr 25, 2024 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 1,000 | $89.55 | $89,550.00 | -0.7% | +16.2% | +68.5% | |
| Apr 24, 2024 | DHR Danaher Corp /de/ | Ellis Brian W62 | Senior Vice President - GC | Sell | 4,000 | $250.01 | $1,000,040.00 | -11.8% | +5.5% | -21.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.